Clinical Trials Directory

Trials / Completed

CompletedNCT05866887

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
4 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

Detailed description

This research study is to conduct a single-arm pilot study to determine the acceptability and feasibility of Sleep ALL Night for children with Acute Lymphoblastic Leukemia (ALL). Participation in this research study is expected to last 1 month. It is expected about 30 children will take part in this research study. The National Cancer Institute (NCI) is providing funding for this research study through a grant.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSleep ALL NightSleep intervention program comprised of a sleep action plan tool and interactive psychoeducation website.

Timeline

Start date
2023-09-26
Primary completion
2024-06-05
Completion
2024-06-05
First posted
2023-05-19
Last updated
2025-06-06
Results posted
2025-06-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05866887. Inclusion in this directory is not an endorsement.